Multiple Sclerosis’ Enlightening Research

Most of the infectious & immune-mediated diseases have a neurological connection. In most of the cases, these illnesses stems from or cause neurological damage which consequently affects the nervous systems. Multiple Sclerosis (MS) is an example of the said diseases that causes physical impairments, brain lesions, chronic pain and speech difficulties among other symptoms. The most common form of this disease is relapsing-remitting multiple sclerosis. DR. Shiva Gopal Vasishta is one of the doctors who is committed to finding the cure and treatment options for such illnesses. Most recently, a research conducted by Immune Tolerance Network (ITN) is the closest people have come in finding a solution for the illness.

The research conducted by the National Institute of Allergy and Infectious Diseases’ sponsorship was carried out over a period of five years and its final five-year report has just been publicized at a medical journal. The test subjects were 24 patients aged between 26-52 years. The doctors stripped them of their immune through chemotherapy after taking samples of their stem cells and later injected the cells back into their bodies in a process called “HDIT/HCT (high-dose immunosuppressive therapy and autologous hematopoietic cell transplant)”. 69% of the patients’ MS stabilized with a few of them showing improvements and recovering some of their physical abilities. According to the findings, this method of treatments is more effective than long-term treatment with normal MS drugs.

  1. Shiva is a neurological & psychiatrist based in New Jersey who studied medicine at the government medical college, graduated in 1979 and completed his residency at Boston University medical center. He has more than 30 years’ experience in the field and is currently part of Eastern Neurodiagnostic Associates but still works closely with Kennedy Health System Cherry Hill Campus. He is also enrolled with medicare so he can prescribe drugs to all the patients with its benefit.

Leave a Reply

Your email address will not be published. Required fields are marked *